Raymond Mankoski

Summary

Affiliation: Bristol-Myers Squibb
Country: USA

Publications

  1. doi Young mania rating scale line item analysis in pediatric subjects with bipolar I disorder treated with aripiprazole in a short-term, double-blind, randomized study
    Raymond Mankoski
    Bristol Myers Squibb Co, Plainsboro, New Jersey 08536, USA
    J Child Adolesc Psychopharmacol 21:359-64. 2011
  2. doi Safety and tolerability of aripiprazole for irritability in pediatric patients with autistic disorder: a 52-week, open-label, multicenter study
    Ronald N Marcus
    Department of Research and Development, Bristol Myers Squibb, 5 Research Parkway, Wallingford, CT 06492, USA
    J Clin Psychiatry 72:1270-6. 2011

Collaborators

  • Ronald N Marcus
  • Robert D McQuade
  • George Manos
  • Randall Owen
  • Lisa Kamen
  • Robert L Findling
  • William H Carson

Detail Information

Publications2

  1. doi Young mania rating scale line item analysis in pediatric subjects with bipolar I disorder treated with aripiprazole in a short-term, double-blind, randomized study
    Raymond Mankoski
    Bristol Myers Squibb Co, Plainsboro, New Jersey 08536, USA
    J Child Adolesc Psychopharmacol 21:359-64. 2011
    ....
  2. doi Safety and tolerability of aripiprazole for irritability in pediatric patients with autistic disorder: a 52-week, open-label, multicenter study
    Ronald N Marcus
    Department of Research and Development, Bristol Myers Squibb, 5 Research Parkway, Wallingford, CT 06492, USA
    J Clin Psychiatry 72:1270-6. 2011
    ..Evaluate the long-term safety and tolerability of aripiprazole in the treatment of irritability in pediatric subjects (6-17 years) with autistic disorder...